| Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma A Jusakul, I Cutcutache, CH Yong, JQ Lim, MN Huang, N Padmanabhan, ... Cancer discovery 7 (10), 1116-1135, 2017 | 722 | 2017 |
| Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection C An, DW Kim, YN Park, YE Chung, H Rhee, MJ Kim Radiology 276 (2), 433-443, 2015 | 181 | 2015 |
| Vessels encapsulating tumor clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma SL Renne, HY Woo, S Allegra, N Rudini, H Yano, M Donadon, L Viganò, ... Hepatology 71 (1), 183-195, 2020 | 131 | 2020 |
| Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI H Rhee, MJ Kim, MS Park, KA Kim The British journal of radiology 85 (1018), e837-e844, 2012 | 88 | 2012 |
| Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications H Rhee, ES Cho, JH Nahm, M Jang, YE Chung, SE Baek, S Lee, MJ Kim, ... Journal of hepatology 74 (1), 109-121, 2021 | 77 | 2021 |
| Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement: more aggressive pathologic features H Rhee, C An, HY Kim, JE Yoo, YN Park, MJ Kim Liver cancer 8 (1), 24-40, 2019 | 77 | 2019 |
| Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis H Rhee, HY Kim, JH Choi, HG Woo, JE Yoo, JH Nahm, JS Choi, YN Park Cancer research 78 (7), 1619-1631, 2018 | 69 | 2018 |
| Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization H Rhee, JH Nahm, H Kim, GH Choi, JE Yoo, HS Lee, MJ Koh, YN Park Modern Pathology 29 (9), 1038-1049, 2016 | 60 | 2016 |
| Transarterial therapies for hepatocellular carcinoma E Lanza, M Donadon, D Poretti, V Pedicini, M Tramarin, M Roncalli, ... Liver cancer 6 (1), 27-33, 2017 | 56 | 2017 |
| Gadoxetic acid‐enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria H Rhee, MJ Kim, YN Park, JS Choi, KS Kim Journal of Magnetic Resonance Imaging 35 (2), 393-398, 2012 | 55 | 2012 |
| Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma TY Na, NL Ka, H Rhee, D Kyeong, MH Kim, JK Seong, YN Park, MO Lee Oncogene 35 (41), 5435-5445, 2016 | 51 | 2016 |
| Added value of subtraction imaging in detecting arterial enhancement in small (< 3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of … C An, MS Park, D Kim, YE Kim, WS Chung, H Rhee, MJ Kim, KW Kim European radiology 23, 924-930, 2013 | 49 | 2013 |
| Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma H Rhee, JE Ko, T Chung, BA Jee, SM Kwon, JH Nahm, JY Seok, JE Yoo, ... Liver International 38 (1), 113-124, 2018 | 47 | 2018 |
| Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma C An, H Rhee, K Han, JY Choi, YN Park, MS Park, MJ Kim, S Park European radiology 27, 2610-2618, 2017 | 47 | 2017 |
| Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma JS Lee, JE Yoo, H Kim, H Rhee, MJ Koh, JH Nahm, JS Choi, KH Lee, ... PLoS One 12 (3), e0171922, 2017 | 46 | 2017 |
| Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior GJ Kim, H Rhee, JE Yoo, JE Ko, JS Lee, H Kim, JS Choi, YN Park PLoS One 9 (8), e105094, 2014 | 46 | 2014 |
| Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) Y Cho, H Rhee, Y Kim, M Lee, BW Lee, ES Kang, BS Cha, JY Choi, Y Lee BMC medicine 20 (1), 93, 2022 | 44 | 2022 |
| The role of imaging in current treatment strategies for pancreatic adenocarcinoma H Rhee, MS Park Korean Journal of Radiology 22 (1), 23, 2021 | 43 | 2021 |
| Dynamics of genomic, epigenomic, and transcriptomic aberrations during stepwise hepatocarcinogenesis BA Jee, JH Choi, H Rhee, S Yoon, SM Kwon, JH Nahm, JE Yoo, Y Jeon, ... Cancer research 79 (21), 5500-5512, 2019 | 41 | 2019 |
| Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression H Rhee, T Chung, JE Yoo, JH Nahm, HY Woo, GH Choi, DH Han, ... Hepatology International 14, 239-248, 2020 | 38 | 2020 |
